Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases: Results From a Nordic Survey.

IF 1.8 Q3 HEALTH CARE SCIENCES & SERVICES
Journal of Patient Experience Pub Date : 2025-07-17 eCollection Date: 2025-01-01 DOI:10.1177/23743735251360485
Meliha Kapetanovic, Randeep Mandla, Susanne Thiesen Gren, Maria Seddighzadeh, Dan Henrohn, Maaria Palmroth, Anna-Maria Hiltunen, Jussi Ranta, Anna-Kaisa Asikainen, Anne Grete Frøstrup, Veli-Jukka Anttila
{"title":"Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases: Results From a Nordic Survey.","authors":"Meliha Kapetanovic, Randeep Mandla, Susanne Thiesen Gren, Maria Seddighzadeh, Dan Henrohn, Maaria Palmroth, Anna-Maria Hiltunen, Jussi Ranta, Anna-Kaisa Asikainen, Anne Grete Frøstrup, Veli-Jukka Anttila","doi":"10.1177/23743735251360485","DOIUrl":null,"url":null,"abstract":"<p><p>A survey on vaccinations was conducted among patients with chronic inflammatory diseases (CIDs), including inflammatory bowel disease, inflammatory rheumatological diseases, and dermatological diseases (DDs). The objective was to identify differences between established vaccination guidelines and actual practices in healthcare as experienced by patients. Among eligible responders (<i>n</i> = 1434), 57% were on immunomodulatory treatment, and 59% were treated in specialized care. The most recommended vaccines were COVID-19 (66%), influenza (63%), and pneumococcal (46%). Regarding common vaccination principles for patients with CID, 61% reported not receiving information on vaccinations before treatment initiation. Only 23% were advised to check their vaccination status before starting medications, and just 20% reported that their vaccination status is regularly assessed. Logistic regression revealed that the DD group was less likely, while patients over 65 years of age or on immunomodulatory treatment were more likely to be recommended and receive vaccinations. Ideally, all CID patients should be eligible for preventive immunization starting from the time of diagnosis. A targeted vaccination program with clear responsibilities across the healthcare system is strongly recommended.</p>","PeriodicalId":45073,"journal":{"name":"Journal of Patient Experience","volume":"12 ","pages":"23743735251360485"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301179/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Patient Experience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23743735251360485","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

A survey on vaccinations was conducted among patients with chronic inflammatory diseases (CIDs), including inflammatory bowel disease, inflammatory rheumatological diseases, and dermatological diseases (DDs). The objective was to identify differences between established vaccination guidelines and actual practices in healthcare as experienced by patients. Among eligible responders (n = 1434), 57% were on immunomodulatory treatment, and 59% were treated in specialized care. The most recommended vaccines were COVID-19 (66%), influenza (63%), and pneumococcal (46%). Regarding common vaccination principles for patients with CID, 61% reported not receiving information on vaccinations before treatment initiation. Only 23% were advised to check their vaccination status before starting medications, and just 20% reported that their vaccination status is regularly assessed. Logistic regression revealed that the DD group was less likely, while patients over 65 years of age or on immunomodulatory treatment were more likely to be recommended and receive vaccinations. Ideally, all CID patients should be eligible for preventive immunization starting from the time of diagnosis. A targeted vaccination program with clear responsibilities across the healthcare system is strongly recommended.

慢性炎症性疾病患者的疫苗知识和意识:来自北欧调查的结果。
对慢性炎症性疾病(cid)患者(包括炎症性肠病、炎症性风湿病和皮肤病(dd))进行了疫苗接种调查。目的是确定已建立的疫苗接种指南与患者所经历的卫生保健实际做法之间的差异。在符合条件的应答者(n = 1434)中,57%接受免疫调节治疗,59%接受专科治疗。推荐最多的疫苗是COVID-19(66%)、流感(63%)和肺炎球菌(46%)。关于CID患者的常见疫苗接种原则,61%的患者报告在开始治疗前未获得疫苗接种信息。只有23%的人被建议在开始用药前检查他们的疫苗接种状况,只有20%的人报告说他们的疫苗接种状况得到了定期评估。Logistic回归显示,DD组的可能性较小,而65岁以上或接受免疫调节治疗的患者更有可能被推荐并接受疫苗接种。理想情况下,所有CID患者应从诊断时开始就有资格进行预防性免疫接种。强烈建议在整个卫生保健系统中制定明确责任的有针对性的疫苗接种计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Patient Experience
Journal of Patient Experience HEALTH CARE SCIENCES & SERVICES-
CiteScore
2.00
自引率
6.70%
发文量
178
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信